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Sepsis is now the leading direct cause of maternal death in the United Kingdom, and Streptococcus pyogenes is the leading patho-
gen.We combined conventional and genomic analyses to define the duration and scale of a lethal outbreak. Two postpartum
deaths caused by S. pyogenes occurred within 24 h; one was characterized by bacteremia and shock and the other by hemorrhagic
pneumonia. The women gave birth within minutes of each other in the samematernity unit 2 days earlier. Seven additional in-
fections in health care and household contacts were subsequently detected and treated. All cluster-associated S. pyogenes isolates
were genotype emm1 and were initially indistinguishable from other United Kingdom emm1 isolates. Sequencing of the viru-
lence gene sic revealed that all outbreak isolates had the same unique sic type. Genome sequencing confirmed that the cluster was
caused by a unique S. pyogenes clone. Transmission between patients occurred on a single day and was associated with casual
contact only. A single isolate from one patient demonstrated a sequence change in sic consistent with longer infection duration.
Transmission to health care workers was traced to single clinical contacts with index cases. The last case was detected 18 days
after the first case. Following enhanced surveillance, the outbreak isolate was not detected again. Mutations in bacterial regula-
tory genes played no detectable role in this outbreak, illustrating the intrinsic ability of emm1 S. pyogenes to spread while retain-
ing virulence. This fast-moving outbreak highlights the potential of S. pyogenes to cause a range of diseases in the puerperium
with rapid transmission, underlining the importance of immediate recognition and response by clinical infection and occupa-
tional health teams.
Cases of postpartummaternal Streptococcus pyogenes sepsis oc-cur sporadically; paired cases and deaths are rare in the devel-
oped world (1, 2). We describe two postpartum deaths due to S.
pyogenes (group A Streptococcus [GAS]) that occurred within 24 h
in the same maternity unit; one case was characterized by septic
shock and the other by hemorrhagic pneumonia. Both cases were
associated with seven additional infections detected in health care
and family contacts. We combined genotypic and phenotypic
analyses with whole-genome sequencing to confirm that the iso-
lates were unique and distinct from other emm1 GAS isolates cir-
culating in the United Kingdom, enabling us to determine the
time limits and scale of this outbreak.
CASE REPORTS
Case 1.A39-year-old teacher (gravida 3, para 2) presented at term
with irregular contractions and was monitored for 5 h in the ma-
ternity unit prior to discharge. She was readmitted 5 h later and
delivered a live female infant. Other than a small second-degree
tear, there were no complications and the mother was discharged
13 h after delivery. Approximately 30 h following delivery she
awoke with lower abdominal pain necessitating hospital readmis-
sion, inhaled nitrous oxide, and opiates, although physiological
measurements were initially normal. She collapsed, 6 h later, with
hypotension and was transferred to the intensive care unit. She
rapidly developed multiorgan failure and responded poorly to
inotropic and ventilatory support in addition to broad-spectrum
antibiotics. The following day, blood cultures indicated a strepto-
coccal infection, and high-dose intravenous pooled human im-
munoglobulin G (IVIG) was administered. The patient deterio-
rated and died 2.5 days after delivery of her third child. GAS was
isolated from blood cultures and genital tract swabs obtained an-
temortem and also from uterine cervix tissue obtained postmor-
tem.
Case 2. A 29-year-old primigravid teacher was admitted while
in labor to the same unit on the same day as case 1. She had
experienced spontaneous rupture of membranes 48 h earlier and
had commenced prophylactic amoxicillin. During the day she had
had a transient temperature of 37.7°C which settled, though other
physiological measurements were normal. An oxytocin infusion
was commenced; 12 h later, a live male infant was delivered by
emergency cesarean section, and a final antibiotic dose was ad-
ministered intraoperatively. The time of cesarean delivery was 2
min before the delivery of the baby of case 1, although the delivery
occurred in a separate section of the maternity unit and was un-
dertaken by different staff. She was discharged approximately 66 h
after cesarean section. Approximately 76 h after delivery, she de-
veloped a cough and chest pain associatedwith blood-stained spu-
tum.A communitymidwife arranged hospital readmission.While
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packing, the patient collapsed in respiratory arrest associated with
hemoptysis. Resuscitation was attempted by a paramedical team
on site and in the hospital emergency unit but the patient died on
24 December, 3.5 days after cesarean section. GAS was isolated
from throat, hemorrhagic lung, and uterine cervix samples post-
mortem but not from the cesarean wound or lower genital tract.
GAS isolates from both cases were subsequently identified as emm
type 1.
Responseof infection teamand intensive surveillance.Ahos-
pital outbreak control team managed the incident, surveillance,
and epidemiology. Household and health care worker (HCW)
contacts of each patient were screened, including antenatal, dur-
ing-labor, and postnatal contacts (Fig. 1). Environmental screen-
ing was conducted once in the immediate aftermath of the out-
break by swabbing of baths, showers, basins, and bed space
surfaces, and the samples obtained by swabbing were cultured on
blood agar.
As part of a 2-month period of intensive surveillance, all moth-
ers who had been on the unit concurrently with the two cases were
contacted and advised to seek medical attention and screening if
symptomatic. All women in labor were screened during this pe-
riod within a day of admission. Throat and skin swabs (if skin
lesionswere reported)were used for screening forGAS, plus lower
genital tract swabs for all women in labor. During the intensive
surveillance period, enhanced twice daily chlorine-based cleaning
in the maternity unit was undertaken (previously once daily de-
tergent-based cleaning).
Screening results. (i) Household contacts. Four household
contacts of case 1were screened, of whom2were positive for GAS.
Two household contacts of case 2 were screened, of whom 1 was
positive for GAS.
The baby of case 1 was admitted to the neonatal unit with a
raised level of C-reactive protein (CRP) and received ceftriaxone
for suspected sepsis; nose and ear swabs obtained 2 days after
delivery yielded GAS emm1, although blood and cerebrospinal
fluid (CSF) cultures were negative. The baby of case 2 was not
colonized or infected with GAS.
Throat swabs from the partners of case 1 and case 2 yielded
GAS emm1, and both of these individuals received antibiotics.
One partner reported pharyngitis at the time of screening (i.e.,
after the death of case 1), while the other developed a lower respi-
ratory tract infection necessitating hospital admission 4 days after
the death of case 2.
(ii) Health care contacts.Of 69 HCW contacts screened, 3/69
(4.3%) had throat swabs that yielded GAS emm1, and each re-
ceived antibiotic treatment. The three HCWs reported single ep-
isodes of postnatal clinical contact with the patients and included
an obstetrician who examined case 1, an intensive care unit (ICU)
nurse present at the intubation of case 1, and a community mid-
wife attending case 2 at home. Two of the HCWs developed sig-
nificant symptoms 7 to 10 days after the deaths; one had tonsillitis
and cervical lymphadenopathy, while the other had pharyngitis.
HCWs who tested positive for GAS were offered 10 days of treat-
ment with oral amoxicillin, removed from work for this period,
and screened again at the end of treatment. The partner of a symp-
tomatic HCWwas treated for GAS pharyngitis, though the isolate
was not available for study.
One hundred ninety-three HCWs from the same institution,
whowere not contacts of the two cases, were also screened. Two of
the 193 (1%) had throat swabs that yielded GAS and received
antibiotics; however, these isolates were emm12.
(iii) Other patients. In the immediate aftermath of the out-
break, 42maternity patientswere screened, includingwomenwho
reported symptoms compatible with GAS and had been on the
FIG 1 Identification of group A streptococcus (GAS) cases. Cumulative number of individuals carrying or infected with the outbreak strain by date (upper axis,
blue-shaded bars). Individualswith the outbreak strain includedmaternity patients (solid shading), household contacts (diagonal crosshatching), andhealth care
workers (HCWs) (horizontal crosshatching). Individuals found to be carrying or infected with other GAS isolates during the period of surveillance are shown on
the lower axis (gray-shaded bars). Period of overlapping hospital admissions for three maternity patients denoted by gray shaded area. During the period of
intense surveillance, which started on December 24 and lasted for 2 months, two HCWs were identified to be carrying emm12 GAS (gray-shaded horizontally
hatched bars) and two nonmaternity patients had community-acquired invasive infections caused by GAS strains emm89 (gray-shaded bar, January 3) and
emm75 (white bar, January 23). Enhanced surveillance continued for a further 4 months, during which time no further GAS was isolated from any maternity
patient.
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unit at the same time as the two fatal cases, along with those ad-
mitted up to 2 weeks later. One of the 42 had a throat swab that
yielded GAS, typed as emm1. This patient reported pharyngitis
and sinusitis that developed 1 week postpartum and also recalled
meeting and talking with case 1 on the day of her original admis-
sion (Fig. 1). This patient was treated with antibiotics in the com-
munity.
Two further cases of invasive GAS infection (necrotizing fas-
ciitis and pneumonia) were admitted from the community during
the month following the maternal fatalities; however, the GAS
isolates in these cases were emm75 and emm89 (Fig. 1).
(iv) Environment. GAS was not isolated from any environ-
mental samples.
(v) Enhanced surveillance. A further 4-month period of en-
hanced clinical surveillancewas institutedwithin the obstetric and
neonatal units, in which HCW were particularly alert for all GAS
infections and swabbed throats and skin of patients or HCW if
there was any history or indication of inflammation. No further
GAS carriage or infection was detected.
MATERIALS AND METHODS
Phenotyping and genotyping of GAS strains. All 15 emm1 GAS isolates
from the cluster were comparedwith 14 other emm1GAS isolates submit-
ted to the national reference laboratory from elsewhere in England in the
3 months preceding and 1 month following the outbreak, including,
where available, isolates from the same region (see Table S1 in the supple-
mental material). GAS phenotypic comparison, emm typing, superanti-
gen genotyping, and covR/S and sic loci sequencing are described in Sup-
plementary Methods in the supplemental material.
GAS whole-genome sequencing. Illumina sequencing was performed
on 24 strains, including all 15 strains from the outbreak, andmapped against
the complete genome sequence of the U.S. emm1 strain MGAS5005 (3). In
excess of 50-fold sequence coverage was achieved for all isolates (see Supple-
mentaryMethods in the supplemental material).
Measurement of anti-emm1 GAS immunity in pregnant women.As
a surrogate for immunity among women of child-bearing age in the
United Kingdom, anonymized serum samples from antenatal screening
were obtained from the Imperial College Healthcare Trust and used in
accordance with approval from the West London Research Ethics Com-
mittee.
Enzyme-linked immunosorbent assay-based assays of immunity.
Reactivity of antenatal sera to recombinant SIC proteins was tested using
an enzyme-linked immunosorbent assay (ELISA)-basedmethod. Diluted
antenatal sera were applied to SIC protein-coated wells, and bound IgG
was detected with goat anti-human IgG-horseradish peroxidase (HRP).
In order to quantify SIC-reactive IgG in each serum sample relative to the
human blood product intravenous immunoglobulin (IVIG) (Zenalb 4.5),
which has high antistreptococcal activity, the activity of IVIG against SIC
proteinwas alsomeasured using a series of fixed concentrations of IVIG to
generate a standard curve of IVIG-equivalent anti-SIC IgG on each plate.
A similar protocol was used to detect IgG reactivity of antenatal sera to
whole emm1 S. pyogenes cells, but the wells were coated with heat-killed
emm1 S. pyogenes. Details are provided in the supplemental methods in
the supplemental material.
Opsonophagocytosis assays of immunity.Assayswere performedus-
ing 80 (of 199) representative heat-inactivated antenatal patient sera.
emm1 GAS (strain H584) isolates were stained with fluorescein isothio-
cyanate (FITC) (Invitrogen) and opsonized with test serum before being
added to 2 106 fresh human neutrophils and 10% complement (rabbit
serum; Merck Chemicals, United Kingdom). Neutrophils with internal-
ized FITC-labeled bacteria were measured by flow cytometry. To exclude
the external adherent, FITC-labeled S. pyogenes, samples were quenched
with trypan blue. Antenatal serum-opsonized GAS isolates were com-
pared with IVIG (2.5 mg/ml)-opsonized GAS isolates, as this has been
shown to provide optimum opsonophagocytosis. Nonopsonized GAS
isolates were used as negative controls.
RESULTS
Phenotypic analysis of GAS isolates. To determine whether the
15 emm1 GAS isolates from thematernity unit exhibited excessive
virulence, they were compared phenotypically with 14 other
emm1 strains from the United Kingdom using a wide panel of in
vitro analyses that included investigations of growth in whole
blood, superantigenicity, and the expression of capsule, Strepto-
coccus pyogenes cell envelope protease (SpyCEP), and cysteine
protease SPEB (see Fig. S1 in the supplemental material). There
were no phenotypic differences detected between the outbreak
cluster and other emm1 strains circulating in the United King-
dom. Isolates were penicillin sensitive, and the MIC did not differ
from other emm1 isolates (0.03 mg/liter).
Molecular analysis of GAS isolates.Although 5 to 10 different
superantigen genotypes have been described in European emm1
strains (4), all 29 outbreak and nonoutbreak strains had the same
superantigen genotype (speA, speG, speJ, and smeZ).
Sequencing of the streptococcal inhibitor of complement
(SIC), encoded by sic, identified 13 different sic alleles among all 29
emm1 isolates studied, the most common allele identified being
sic1.02 (see Table S1 in the supplemental material). Of the 15
emm1 isolates from the maternity unit, 14 had the same sic gene,
which had a unique gene sequence and was designated sic1.300.
One genital tract isolate from case 1 demonstrated another unique
sic allele, designated sic1.301. As sic1.301 differed from sic1.300 by
an 87-bp deletion (see Fig. S2 in the supplemental material), we
surmised that sic1.301 had arisen from sic1.300 during mucosal
carriage indicating possible longer duration of infection (5, 6).
Despite distinctive sequences, there were no differences in the
abilities of the recombinant variant SIC proteins to inhibit com-
plement-mediated erythrocyte lysis (SIC1.300, SIC1.301, and the
common United Kingdom type SIC1.02) (see Fig. S2 in the sup-
plemental material), a finding that is consistent with those re-
ported in published structure-function data (5, 7).
Whole-genome sequencing. To determine if any features in
addition to those revealed by the sic genotyping distinguished the
isolates, we performed whole-genome sequencing of the 15 emm1
isolates from the maternity unit and 9 of the 14 unrelated emm1
isolates from elsewhere in England.
Genome sequencing confirmed that the 15 strains from the
maternity unit were unique and differed from the nearest GAS
relative by eight core genome single nucleotide polymorphisms
(SNPs); six of these SNPswere unique to the outbreak cluster (Fig.
2). Of the six unique SNPs, one was nonsynonymous and oc-
curred in the sic gene (consistent with the previously noted unique
sic gene sequence). Additionally, outside the core genome, the
outbreak cluster had a unique nonsynonymous SNP that mapped
to a gene of unknown function in phage 5005.2.
Comparing all 24 sequenced emm1 strains with the genome of
MGAS5005, themost recently sequencedU.S. emm1 strain (3), we
identified a total of 250 SNP loci within the core genome (exclud-
ing phage-related sequences), of which 138 (55%)were nonsyn-
onymous substitutions, 80 (32%) were synonymous substitu-
tions, and 32 (13%) were within intergenic regions (see Tables
S2, S3, and S4 in the supplemental material).
Mutations in GAS regulatory genes, reported to be associated
with strain hyperinvasiveness, were not seen in any of the 15 iso-
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lates from thematernity unit. Uniquemutations in covR/S and rgg
were seen in only 2/7 and 1/7 invasive emm1 strains from else-
where in England, respectively, and these were associated with
predicted phenotypic changes that included increased SpyCEP
and capsule expression but reduced SPEB expression (see Fig. S1
in the supplemental material).
During the short outbreak course, no new SNPs arose in the 15
isolates from the maternity unit. However, in addition to the sic
deletion mutation already detected in a genital tract isolate from
case 1, a truncation deletion mutation in the capsule biosynthesis
gene, hasB, was identified in a pharyngeal isolate cultured from the
maternity patient contact with an 11-day history of pharyngitis.
This mutation had no measurable impact on capsule production
in vitro (see Fig. S1 in the supplemental material).
Immunity to emm1 GAS in antenatal population. To inves-
tigate antenatal population immunity to emm1 GAS, 199 sera
were tested for reactivity to each SIC allele (sic being specific to
emm1) and to emm1 GAS surface proteins. Of the 199 sera, 7%
showed no recognition of SIC, while a majority showed low
reactivity and a small proportion (8%) showed strong reactiv-
ity similar to IVIG. SIC allele-specific responses were seen only
in a minority (see Fig. S3 in the supplemental material). Only
16% of the 199 antenatal sera had any detectable antibody to
GAS surface proteins (see Fig. S4).
The ability of antenatal sera to opsonize FITC-labeled emm1
GAS was determined by coincubation with fresh human neutro-
phils and measurement of subsequent phagocytosis; 5% of sam-
ples demonstrated no ability to facilitate opsonophagocytosis of
emm1 GAS, while only 4% showed activity equivalent to that seen
when we tested human IVIG (Fig. 3).
DISCUSSION
This lethal outbreak of emm1 S. pyogenes in a maternity unit was
explosive, commencing with a likely community source. Trans-
FIG 2 Phylogenetic analysis results demonstrating that the core genomes of the maternity unit isolates were identical to each other but different from
contemporaneous emm1 isolates submitted to the reference laboratory. The genomes of all 15 isolates from thematernity unit and 9 emm1 isolates from around
Englandwere sequenced andmapped to the complete genome sequence ofMGAS5005, a contemporaryU.S. strain (3). Amaximum-likelihood phylogenetic tree
was generated from core genome single nucleotide polymorphisms (SNPs) of 24 emm1 isolates. Thematernity unit isolates clustered in a single clade that differed
from the nearest relative by eight SNPs. The sic allele for each isolate is indicated. The unique sic allele (sic1.301) that arose within the outbreak cluster is
highlighted in red. The scale bar represents substitutions per SNP site. Details of all SNPs are provided inTable S2 in the supplementalmaterial. HCW, health care
worker; URT, upper respiratory tract; LRT, lower respiratory tract; GT, genital tract.
FIG 3 Immunity to emm1 GAS among healthy pregnant women. The ability
of antenatal sera to opsonize FITC-labeled M1 GAS is shown for 80 represen-
tative sera (out of 199). The percentage of neutrophils associated with serum-
opsonized FITC-labeled bacteria was measured by flow cytometry and ex-
pressed relative to the percentage of neutrophils associated with FITC-labeled
bacteria when IVIG (2.5 mg/ml) was used as the opsonin. Negative, below the
level of the “no serum” (complement alone) control (10% of IVIG-equiva-
lent opsonophagocytosis).
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mission events occurred on a single day with apparently transient
contacts.Whole-genome sequencing confirmed cases to be clonal,
although events were so rapid that a chronological sequence of
transmission could be determined only by changes in a virulence
gene, sic, rather than conventional analysis of whole-genome data.
The rapid and lethal nature of this outbreak highlights a num-
ber of learning points. First, GAS infection remains a deadly threat
in the puerperium. The transmission risk within the maternity
setting is high, not only to HCWs who attend infected patients,
but also between social and family contacts and to the newborn
infant. Oropharyngeal carriage may be important, and single ep-
isodes of contact are sufficient for productive transmission to oc-
cur (including both social and health care contact). Recognized
risk factors for postpartum sepsis may not always be present, and
signs of severe sepsismay bemasked or present atypically. Invasive
GAS infection in the postpartum period is not limited to classical
genital tract (puerperal) sepsis and may present to physicians
other than obstetricians, progressing rapidly to irreversible mul-
tiorgan failure.
Remarkably, sepsis is now the leading cause of “direct” mater-
nal deaths in the United Kingdom. GAS accounted for 13 of 25
sepsis-related maternal deaths reported in 2006–2008 by the
United Kingdom Centre for Maternal and Child Enquiries
(CMACE), although the reasons for the increases are unclear (8,
9). Although pairs of GAS infection caused by the same emm type
have been previously reported in maternity units, such events are
rare andmay be related toHCWcarriage (1, 10, 11). The outbreak
we describe was caused by emm1 GAS, the major lineage associ-
ated with invasive disease in Europe and the United States. Al-
though GAS puerperal sepsis is most frequently associated with
emm28, the mortality of GAS puerperal infection is dispropor-
tionately attributable to emm1 and emm3 S. pyogenes isolates (12).
Environmental factors that influence GAS outbreaks have been
well documented (seasonal variation, sharing rooms, hygiene,
etc.) (13–16), but the host and the pathogen factors affecting
transmission of S. pyogenes in this setting are unknown.
The affected women were admitted while in labor to the same
unit on the same day. It is not possible to definitively determine
whether infection was acquired outside the hospital and then
transmitted sequentially through person-to-person contact
within the unit or whether the maternity patients acquired their
infection from a common source. However, one isolate (out of
four) from case 1 had undergone allelic change in sic at an un-
known time point, indicative of longer mucosal colonization.
Changes in sic within individual patients carrying GAS mucosally
have been reported previously, as have changes during epidemics
within a population (5, 17), but these events may require pro-
longed carriage (2 weeks). Indeed, experimental mucosal infec-
tion of mice failed to induce allelic change in sic over a 9-day
period (data not shown), a result consistent with those of other
studies (5, 6). Due to the high numbers of repeat regions within
the sic gene, the mapping software used to analyze whole-genome
sequencing cannot identify such changes, necessitating conven-
tional sequencing. Although both women delivered within min-
utes of one another, symptomatic infection in case 2 arose 2 days
later than in case 1. We speculate that the administration of pro-
phylactic beta lactam antibiotics for ruptured membranes in case
2may have delayed the onset of disease, although these antibiotics
were insufficient to prevent GAS acquisition or colonization.
The routes of GAS transmission in the puerperium are hard to
investigate, since samples are seldom obtained fromwomen ante-
natally or from contacts, except where an outbreak occurs. GAS is
rarely present in the genital tract antenatally (18–21); hence,
screening or clearance regimens, antenatally or intrapartum, are
unlikely to have an impact on postpartum GAS infection. The
importance of the respiratory tract as a source of infection in re-
cently pregnant women was established in the 1930s, and reiter-
ated in the CMACE report (8, 18). GAS throat carriage among
healthy adults in England is low, around 0.5 to 2% (22), consistent
with the 1% carriage rate (of nonoutbreak strains) we detected in
HCWswhowere not direct contacts of the cases. In contrast, 4.3%
of the HCWs identified as contacts were found to be carriers or
infected with the outbreak strain, suggesting that it may be espe-
cially suited to spreading in this setting. Transmission of the out-
break strain to HCWs was, however, limited to those reporting
close but single clinical contacts, and this raises the question as to
whether mask wearing is advisable for HCWs treating GAS pa-
tients. Screening of HCWs was performed using throat or skin
swabs and thus excluded those carrying GAS rectally or vaginally.
Previous outbreaks have been associated with HCWs asymptom-
atically carryingGAS at allmucosal sites (11); therefore, we cannot
fully exclude anunknownHCWsource ofGAS.HCWcompliance
is essential during outbreak investigation (13, 23), and newly is-
sued United Kingdom guidance (14) recommends that nasal, rec-
tal, and vaginal swabs should be obtained, if other swabs are neg-
ative, in situations where an HCW is implicated in transmission.
Contact with children in either the home or the workplace has
been reported in associationwithmaternal invasiveGAS infection
(8); coincidentally, bothwomenwho diedwere teachers, although
they taught at separate schools. While it is possible that children
represented a reservoir for the outbreak strain, the strain was not
detected in any of 193 HCWs that were not contacts of the pa-
tients, nor was it identified among 100 GAS throat isolates sub-
mitted from the affected region in the 1 year following the out-
break. We therefore concluded that the outbreak strain was not
circulating in the wider community.
Women after delivery are 20 times more susceptible to hemo-
lytic streptococcal bacteremia than nonpregnant women; this risk
increases to 100-fold if all invasive GAS infections are included
(24, 25). There is a pressing need to establish a robust assay for
GAS immunity that can be applied to large populations. To deter-
mine immunity in a similar but unrelated antenatal population,
we used an assay that solelymeasured serumopsonic function that
could result in phagocytosis. Five percent of antenatal sera showed
no opsonic activity against emm1GAS, highlighting an underlying
susceptibility to GAS infection in a significant proportion of the
antenatal population.Whether immunity toGAS alters during the
course of pregnancy is entirely unknown and is a subject of ongo-
ing research.
To our knowledge, the emm1 GAS isolates in this study are the
first to be sequenced outside the United States. For comparison
and SNP identification, we chose to align our sequences against
the emm1 genome strain MGAS5005 (rather than SF370), as the
MGAS5005 strain is more representative of the globally dissemi-
nated emm1 clone (3). Mutations in regulatory genes are report-
edly characteristic of emm1 hyperinvasiveness (26–28) but may
result in fitness cost, reducing colonization potential (29).
These mutations were not observed in any of the outbreak
strains and were observed in fewer than half of the invasive
emm1 strains from elsewhere in England. Preservation of GAS
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regulatory gene function may have underpinned the rapid
transmissibility and adaptability essential for this explosive but
short-lived outbreak.
This outbreak illustrates the devastating rapidity and inten-
sity with which GAS can spread within a susceptible population
and draws attention to the need for urgent infection control
intervention, including immediate staff screening in a sus-
pected outbreak to prevent consequent additional transmis-
sion events. Staff screening should occur prior to the availability of
the results of molecular typing and ideally before staff members
return to duty, although thismay necessitate a flexible approach to
the screening process rather than the conventional use of occupa-
tional health units.
The emm1GAS organism is equipped with a range of virulence
factors that allow it to cause the spectrum of disease observed in
this outbreak (30), from asymptomatic colonization through to
tonsillitis, hemorrhagic pneumonia, and bacteremia toxic shock.
Recent guidelines regarding outbreak prevention (14) and man-
agement of severe sepsis in the obstetric patient are timely (31).
When reviewing maternity patients presenting after childbirth,
vigilance is needed with regard to suspicion of sepsis, which may
develop in the community, as occurred in both cases reported
here.
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